| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.4M | -36.8% | -14.1% |
| SG&A Expense | $1.8M | +5.4% | +23.1% |
| Operating Income | -$3.1M | +18.4% | -3.5% |
| Pre-tax Income | -$3.0M | +18.3% | -1.3% |
| Net Income | -$3.0M | +18.3% | -1.3% |
| EPS (Basic) | -$0.41 | +37.9% | +85.7% |
| EPS (Diluted) | -$0.41 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.1M | -42.9% | -56.0% |
| Current Assets | $5.5M | -36.0% | -43.5% |
| Total Assets | $13.6M | -19.9% | -26.9% |
| Current Liabilities | $1.4M | -20.7% | +108.5% |
| Total Liabilities | $1.4M | -22.2% | +72.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.8M | — | — |
| Financing Cash Flow | $7.1M | — | — |
| +37.9% |
| +85.7% |
| $12.2M |
| -19.6% |
| -31.5% |